Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 12/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19645413 | 0.94 | ACE (0.69) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL20227445 | 0.83 | ACE (0.67) | ACELMNA | |
| SCHEMBL16624673 | 0.82 | ACE (0.56) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL13173445 | 0.81 | ACE (0.69) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL13930194 | 0.80 | ACE (0.52) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL10961687 | 0.79 | ACE (0.94) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL20218251 | 0.79 | ACE (0.63) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL4671537 | 0.78 | ACE (0.61) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL4671532 | 0.78 | ACE (0.61) | ACELMNAABCB11SMN1; SMN2MEN1 | |
| SCHEMBL10729338 | 0.78 | ACE (0.60) | ACELMNAABCB11SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025229501-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ENALAPRIL MALEATE, USE AND PREPARATION METHOD | LABORATORIOS ANDRÓMACO S.A. (CL) | 2025-11-06 | — | — | WO | disclosed |